Published in Antimicrob Agents Chemother on January 01, 1982
Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli. Antimicrob Agents Chemother (1989) 1.54
Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis. Antimicrob Agents Chemother (1983) 1.47
Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob Agents Chemother (1990) 1.20
Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother (1993) 1.18
Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats. Antimicrob Agents Chemother (1985) 1.17
Comparison of the concentrations of ceftazidime in the serum of newborn infants after intravenous and intramuscular administration. Antimicrob Agents Chemother (1983) 1.09
Ceftazidime therapy of serious bacterial infections. Antimicrob Agents Chemother (1983) 1.03
The β-Lactams Strike Back: Ceftazidime-Avibactam. Pharmacotherapy (2015) 0.99
High-pressure liquid chromatographic analysis of ceftazidime in serum and urine. Antimicrob Agents Chemother (1983) 0.94
Ceftazidime as initial therapy for suspected bacterial infections in hospitalized pediatric patients. Antimicrob Agents Chemother (1984) 0.86
Randomized comparison of ceftazidime versus clindamycin-tobramycin in the treatment of obstetrical and gynecological infections. Antimicrob Agents Chemother (1983) 0.84
Ceftazidime in the treatment of pediatric patients with severe urinary tract infections due to Pseudomonas spp. Antimicrob Agents Chemother (1984) 0.83
Randomized evaluation of ceftazidime or ticarcillin and tobramycin for the treatment of osteomyelitis caused by gram-negative bacilli. Antimicrob Agents Chemother (1986) 0.83
In vitro comparison of Pseudomonas aeruginosa isolates with various susceptibilities to aminoglycosides and ten beta-lactam antibiotics. Antimicrob Agents Chemother (1984) 0.83
Evaluation of combination chemotherapy in a lightly anesthetized animal model of Pseudomonas pneumonia. Antimicrob Agents Chemother (1987) 0.80
Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumonia. Antimicrob Agents Chemother (1985) 0.77
Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia. Antimicrob Agents Chemother (1985) 0.77
In vitro antibacterial activity of the combination of clindamycin and ceftazidime. Antimicrob Agents Chemother (1984) 0.75
[Ceftazidime in the treatment of pediatric infections--a review]. Infection (1987) 0.75
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother (1972) 61.10
The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics. J Antimicrob Chemother (1976) 18.58
Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother (1974) 10.72
HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1979) 10.60
Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds. Antimicrob Agents Chemother (1979) 10.01
Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases. Antimicrob Agents Chemother (1974) 9.66
Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin. Antimicrob Agents Chemother (1979) 7.65
GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity. Antimicrob Agents Chemother (1980) 6.77
Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother (1980) 3.14
Structure-activity relationships related to ceftizoxime (FK 749). Med Res Rev (1981) 1.48
The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts. J Biol Chem (1965) 22.76
Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother (1974) 10.72
HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1979) 10.60
In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim. Antimicrob Agents Chemother (1982) 10.08
Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds. Antimicrob Agents Chemother (1979) 10.01
Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases. Antimicrob Agents Chemother (1974) 9.66
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1984) 8.62
beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin. Antimicrob Agents Chemother (1978) 8.28
Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin. Antimicrob Agents Chemother (1979) 7.65
Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother (1978) 7.39
The new beta-lactamase-stable cephalosporins. Ann Intern Med (1982) 7.20
Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity. Antimicrob Agents Chemother (1978) 5.81
Purification and characterization of penicillinases from Salmonella typhimurium and Escherichia coli. Arch Biochem Biophys (1970) 5.39
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim. Antimicrob Agents Chemother (1983) 5.21
Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins. Antimicrob Agents Chemother (1978) 4.69
Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability. Antimicrob Agents Chemother (1982) 4.45
Azlocillin and mezlocillin: new ureido penicillins. Antimicrob Agents Chemother (1978) 4.28
Clavulanic acid, a novel inhibitor of beta-lactamases. Antimicrob Agents Chemother (1978) 4.27
Release of surface enzymes in Enterobacteriaceae by osmotic shock. J Bacteriol (1967) 4.05
In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone. Antimicrob Agents Chemother (1986) 3.98
Carbenicillin: clinical and laboratory experience with a parenterally administered penicillin for treatment of Pseudomonas infections. Ann Intern Med (1969) 3.62
On the surface localization of enzymes in E. coli. Biochem Biophys Res Commun (1964) 3.52
Relation of beta-lactamase activity and cellular location to resistance of Enterobacter to penicillins and cephalosporins. Antimicrob Agents Chemother (1972) 3.50
Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother (1981) 3.50
In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1984) 3.45
Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin. Antimicrob Agents Chemother (1984) 3.40
In vitro study of netilmicin compared with other aminoglycosides. Antimicrob Agents Chemother (1976) 3.35
In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother (1976) 3.25
In vitro studies of tobramycin, an aminoglycoside antibiotic. Antimicrob Agents Chemother (1972) 3.23
Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin. Antimicrob Agents Chemother (1975) 3.17
Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother (1980) 3.14
Infective endocarditis--an evolving disease. A review of endocarditis at the Columbia-Presbyterian Medical Center, 1968-1973. Medicine (Baltimore) (1978) 3.03
In vitro activity of teichomycin compared with those of other antibiotics. Antimicrob Agents Chemother (1983) 3.00
Comparative inhibition beta-lactamases by novel beta-lactam compounds. Antimicrob Agents Chemother (1979) 2.97
The surface localization of penicillinases in Escherichia coli and Salmonella typhimurium. Biochem Biophys Res Commun (1968) 2.76
The comparative beta-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime. J Antibiot (Tokyo) (1979) 2.67
Pharmacokinetics of cefotaxime. Antimicrob Agents Chemother (1979) 2.67
Infective endocarditis at the Presbyterian Hospital in New York City from 1938-1967. Am J Med (1971) 2.66
The 5'-nucleotidase of Escherichia coli. I. Purification and properties. J Biol Chem (1967) 2.59
Antibacterial activity of a monocyclic beta-lactam SQ 26,776. J Antimicrob Chemother (1981) 2.59
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis (1998) 2.56
The inhibitory quotient. A method for interpreting minimum inhibitory concentration data. JAMA (1981) 2.55
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969). Antimicrob Agents Chemother (1988) 2.52
Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria. Antimicrob Agents Chemother (1976) 2.42
Cefaclor: in vitro spectrum of activity and beta-lactamase stability. Antimicrob Agents Chemother (1978) 2.42
Testing the physician's knowledge of antibiotic use: Self-assessment and learning via videotape. N Engl J Med (1975) 2.35
Septicemia with non-typhoid salmonella. Medicine (Baltimore) (1974) 2.31
Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620. Antimicrob Agents Chemother (1986) 2.26
Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis (1996) 2.23
New macrolide antibiotics: azithromycin and clarithromycin. Ann Intern Med (1992) 2.22
Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases. Am J Med (1985) 2.15
Bone and joint infections due to Salmonella. J Infect Dis (1978) 2.14
Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa. Lancet (1986) 2.14
Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria. Am J Med (1987) 2.13
Antimicrobial resistance and R-factor transfer among isolates of Salmonella in the northeastern United States: a comparison of human and animal isolates. J Infect Dis (1975) 2.09
Direct detection and amplification of Helicobacter pylori ribosomal 16S gene segments from gastric endoscopic biopsies. Diagn Microbiol Infect Dis (1991) 2.06
The pharmacokinetic and bactericidal characteristics of oral cefixime. Clin Pharmacol Ther (1985) 1.99
The nephrotoxicity of antimicrobial agents (first of three parts). N Engl J Med (1977) 1.93
Rapid, reproducible enzyme immunoassay for gentamicin. J Clin Microbiol (1980) 1.92
In vitro studies of cephanone, a 3-heterocyclic-thiomethyl cephalosporin derivative. J Antibiot (Tokyo) (1973) 1.90
Oligonucleotide probe for detection and identification of Campylobacter pylori. J Clin Microbiol (1989) 1.90
Antibacterial activity and beta-lactamase stability of temocillin. Antimicrob Agents Chemother (1982) 1.87
A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor. J Antibiot (Tokyo) (1978) 1.82
In vitro activity of sparfloxacin. Antimicrob Agents Chemother (1991) 1.79
The nephrotoxicity of antimicrobial agents (second of three parts). N Engl J Med (1977) 1.79
In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents. Antimicrob Agents Chemother (1986) 1.79
In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents. J Antimicrob Chemother (1985) 1.78
Semisynthetic penicillin 6-(D(--)-alpha-carboxy-3-thienylacetamido) penicillanic acid active against Pseudomonas in vitro. Appl Microbiol (1971) 1.77
Pharmacokinetics of ticarcillin in patients with abnormal renal function. J Infect Dis (1976) 1.77
Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. J Infect Dis (1978) 1.75
In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem. Antimicrob Agents Chemother (1986) 1.74
Gentamicin in 1978. Ann Intern Med (1978) 1.73
In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins. Antimicrob Agents Chemother (1982) 1.70
In vitro activity and beta-lactamase stability of U-63196E, a novel cephalosporin. Antimicrob Agents Chemother (1983) 1.69
Inactivation of beta-lactam antibiotics by Legionella pneumophila. Antimicrob Agents Chemother (1979) 1.69
Digoxin-inactivating bacteria: identification in human gut flora. Science (1983) 1.68
Kinetics of mezlocillin and carbenicillin. Clin Pharmacol Ther (1978) 1.65
Postsplenectomy infection. Surg Clin North Am (1981) 1.63
In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins. Antimicrob Agents Chemother (1978) 1.62
The release of ribonuclease into the medium when E. coli cells are converted to spheroplasts. Biochem Biophys Res Commun (1964) 1.62
Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods. Antimicrob Agents Chemother (1976) 1.62
In vitro activity and beta-lactamase stability of cefmenoxime. Antimicrob Agents Chemother (1982) 1.62
Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin. Antimicrob Agents Chemother (1979) 1.60
In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074). Antimicrob Agents Chemother (1986) 1.60
Antimicrobial activity and human pharmacology of amoxicillin. J Infect Dis (1974) 1.59
The role of Pseudomonas aeruginosa in infections. J Antimicrob Chemother (1983) 1.57
In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones. Antimicrob Agents Chemother (1988) 1.56
Gastrointestinal histoplasmosis. Dig Dis Sci (1988) 1.54
Comparative antibacterial activity of a new oral cephalosporin, BMY-28100. Antimicrob Agents Chemother (1987) 1.54
Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis (1993) 1.54